Description
Basic introduction
This is a catalog blend of a CJC-related GHRH analog and ipamorelin. It brings two named research components into one listing, so composition and the exact CJC form are important parts of the material specification.
The individual components have different experimental backgrounds. Research on a single component is useful for designing a comparison, but it does not establish the behavior, stability or superiority of a combined vial.
Mechanism of action · Research context
GHRH-related component
The CJC component belongs to GHRH analog research. Confirm whether the material includes DAC or another modification before selecting a published analog as a scientific comparator.
Secretagogue component
Ipamorelin is a separate pentapeptide secretagogue. Its original characterization included pituitary and animal experiments, with hormone release measured as a functional response.
Convergent experimental endpoints
Different pathways may converge on hormone release. A measured combined response does not demonstrate synergy unless the experiment includes a suitable design and each component alone.
Extended research considerations
Blend composition
Confirm the amount and identity of each component. Total powder mass cannot reveal their individual proportions or establish that both peptides retain their intended structure.
Compatibility measurements
Mixture stability is its own analytical question. Examine intact-component recovery and assay compatibility instead of assuming that single-component handling data transfer unchanged to a blend.
Comparative study design
Vehicle, each constituent and the blend provide different controls. Keeping those conditions separate makes it possible to interpret a response without attributing every change to a combined mechanism.
Material and packaging
Listed appearance: White Lyophilized Powder.
Available kit specifications: 10 mg × 10 vials. Select an option above to view its current price and availability.
Storage and handling
Source-listed storage condition: Store at -20°C (Protect from light and moisture). Follow the handling instructions supplied with the actual batch and your laboratory's procedures.
Analytical documentation
Reference analytical documents are available with this listing. Check the material identity, batch number and test date against the batch supplied; contact us for current batch documentation.
Scientific references
These publications describe the studied molecules and experimental models. They do not certify the identity, quality or effects of a particular supplied batch.
- Ipamorelin experimental characterization
- Modified CJC-1295 research context

View report
Marlow Rhea –
I conduct separate random blind HPLC spot quality audits for both CJC-1295 and Ipamorelin on randomly selected vials from every shipment batch, each compound consistently hits the advertised ≥99% independent purity threshold with no unknown impurity peaks visible on chromatogram outputs. Complete dual-component batch purity certification documents ship alongside every order, fully compliant for university lab audit and academic research manuscript submission standards.
Hestia N. –
This dual-peptide mix streamlines my aesthetics and fat metabolism research massively. Instead of weighing and mixing two separate single-peptide vials manually, each CP10 vial delivers the exact balanced ratio of CJC 1295 (No DAC) and Ipamorelin pre-blended at production. All glass vials arrived fully intact during cross-border shipping.
Jasper Carter –
I’ve reordered CP10 monthly for 10 months, it’s my exclusive dual CJC 1295 + Ipamorelin blend supplier. Separate high purity checks for both peptides, clear -20°C dark storage rules, consistent fixed ratio formula solved all unstable data issues I had with separate peptide purchases and cheap generic blends.
Jocelyn P. –
I’ve sourced separate CJC and Ipamorelin batches from dozens of suppliers before, and this pre-blended lyophilized CP10 offers far better uniform solubility for both peptides together. Gentle swirling achieves full dissolution without harsh shaking that damages either peptide’s amino acid chain.
Kael Q. –
The 10mg combined vial capacity eliminates waste for my mid-sized dosing trials. I only reconstitute one pre-blended vial per testing round, removing the risk of inaccurate manual mixing ratios that skewed my old lab data when using standalone peptide vials.